Geneos Wealth Management’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$825K Sell
22,638
-469
-2% -$19.4K 0.02% 638
2026
Q2
$984K Hold
23,107
– – 0.02% 547
2026
Q1
$935K Sell
23,107
-382
-2% -$16.9K 0.02% 523
2025
Q4
$1.08M Buy
23,489
+747
+3% +$34.1K 0.03% 484
2025
Q3
$1.04M Sell
22,742
-21
-0.1% -$930 0.03% 478
2025
Q2
$939K Buy
22,763
+158
+0.7% +$5.86K 0.02% 550
2025
Q1
$790K Buy
22,605
+40
+0.2% +$1.51K 0.03% 508
2024
Q4
$864K Buy
+22,565
New +$850K 0.03% 452
2022
Q4
– Sell
-11,261
Closed -$306K – 2029
2022
Q3
$306K Sell
11,261
-8,143
-42% -$261K 0.02% 497
2022
Q2
$582K Sell
19,404
-26
-0.1% -$859 0.03% 459
2022
Q1
$732K Sell
19,430
-24
-0.1% -$888 0.03% 445
2021
Q4
$783K Sell
19,454
-1,395
-7% -$54.6K 0.03% 463
2021
Q3
$759K Buy
20,849
+1,400
+7% +$50.6K 0.03% 463
2021
Q2
$665K Hold
19,449
– – 0.03% 481
2021
Q1
$591K Hold
19,449
– – 0.02% 592
2020
Q4
$584K Sell
19,449
-2,216
-10% -$55.3K 0.02% 498
2020
Q3
$469K Buy
21,665
+548
+3% +$12.2K 0.02% 446
2020
Q2
$457K Sell
21,117
-1,041
-5% -$22.8K 0.03% 432
2020
Q1
$416K Sell
22,158
-1,103
-5% -$28.3K 0.03% 409
2019
Q4
$600K Buy
23,261
+25
+0.1% +$621 0.03% 404
2019
Q3
$557K Buy
23,236
+2,608
+13% +$58.8K 0.03% 388
2019
Q2
$438K Buy
20,628
+27
+0.1% +$569 0.03% 438
2019
Q1
$427K Buy
20,601
+34
+0.2% +$659 0.03% 439
2018
Q4
$347K Buy
20,567
+29
+0.1% +$539 0.03% 455
2018
Q3
$406K Buy
20,538
+423
+2% +$8.01K 0.03% 431
2018
Q2
$362K Buy
20,115
+34
+0.2% +$605 0.03% 392
2018
Q1
$348K Sell
20,081
-367
-2% -$6.62K 0.03% 385
2017
Q4
$395K Sell
20,448
-619
-3% -$11.6K 0.04% 362
2017
Q3
$386K Buy
21,067
+29
+0.1% +$507 0.04% 352
2017
Q2
$366K Buy
21,038
+1,719
+9% +$28.8K 0.04% 352
2017
Q1
$313K Buy
19,319
+36
+0.2% +$568 0.03% 380
2016
Q4
$282K Buy
19,283
+768
+4% +$11.7K 0.04% 379
2016
Q3
$289K Buy
18,515
+499
+3% +$7.61K 0.04% 366
2016
Q2
$266K Buy
18,016
+428
+2% +$6.38K 0.04% 378
2016
Q1
$270K Hold
17,588
– – 0.04% 362

Other funds holding BN

Geneos Wealth Management's BN Position: Q3 2026 in Review

Geneos Wealth Management reduced its Brookfield (BN) stake by 2% in Q3 2026, selling an estimated $19.4K and leaving 22,638 shares worth $825K. The position accounts for 0.02% of the portfolio, ranked #638.

Geneos Wealth Management first reported a position in BN in Q1 2016 and has held it in 35 quarters since. The position peaked at $1.08M in Q4 2025. 899 funds tracked by Wall St. Rank hold BN as of Q3 2026.

  • Geneos Wealth Management held 22,638 shares of Brookfield worth $825K as of Q3 2026.
  • Geneos Wealth Management sold 469 Brookfield shares in Q3 2026, an estimated $19.4K.
  • Brookfield made up 0.02% of Geneos Wealth Management's portfolio in Q3 2026, its #638 holding.
  • Geneos Wealth Management first reported a position in Brookfield in Q1 2016 and has held it in 35 quarters since.
  • Geneos Wealth Management's Brookfield position peaked at $1.08M in Q4 2025.
  • 899 funds tracked by Wall St. Rank held Brookfield as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.